RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Beijing Tiantan Biological Products Corp Stock

Beijing Tiantan Biological Products Corp Net Income 2024

Beijing Tiantan Biological Products Corp Net Income

1.37 B CNY

Ticker

600161.SS

ISIN

CNE000000WF9

In 2024, Beijing Tiantan Biological Products Corp's profit amounted to 1.37 B CNY, a 23.77% increase from the 1.11 B CNY profit recorded in the previous year.

The Beijing Tiantan Biological Products Corp Net Income history

YEARNET INCOME (undefined CNY)
2026e1.92
2025e1.64
2024e1.37
20231.11
20220.88
20210.76
20200.64
20190.61
20180.51
20171.17
20160.26
20150.01
20140.13
20130.37
20120.3
20110.23
20100.17
20090.21
20080.19
20070.1
20060.1
20050.07
20040.05

Beijing Tiantan Biological Products Corp Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Beijing Tiantan Biological Products Corp, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Beijing Tiantan Biological Products Corp from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Beijing Tiantan Biological Products Corp’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Beijing Tiantan Biological Products Corp. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Beijing Tiantan Biological Products Corp’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Beijing Tiantan Biological Products Corp’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Beijing Tiantan Biological Products Corp’s growth potential.

Beijing Tiantan Biological Products Corp Revenue, EBIT and net profit per share

DateBeijing Tiantan Biological Products Corp RevenueBeijing Tiantan Biological Products Corp EBITBeijing Tiantan Biological Products Corp Net Income
2026e8.14 B undefined2.57 B undefined1.92 B undefined
2025e7.02 B undefined2.13 B undefined1.64 B undefined
2024e6.01 B undefined1.76 B undefined1.37 B undefined
20235.18 B undefined1.72 B undefined1.11 B undefined
20224.26 B undefined1.33 B undefined880.92 M undefined
20214.11 B undefined1.18 B undefined760.01 M undefined
20203.45 B undefined1.07 B undefined639 M undefined
20193.28 B undefined1.02 B undefined611.1 M undefined
20182.93 B undefined856.7 M undefined509.5 M undefined
20172.48 B undefined776.5 M undefined1.17 B undefined
20162.14 B undefined442.2 M undefined256.9 M undefined
20151.62 B undefined291.8 M undefined10 M undefined
20141.83 B undefined396.8 M undefined128.4 M undefined
20131.84 B undefined564.9 M undefined372 M undefined
20121.5 B undefined446.4 M undefined304.9 M undefined
20111.39 B undefined405.6 M undefined233.3 M undefined
20101.2 B undefined276.2 M undefined174.9 M undefined
20091.1 B undefined374.5 M undefined211.7 M undefined
2008967.7 M undefined341 M undefined193.4 M undefined
2007530.5 M undefined195.5 M undefined104.7 M undefined
2006416.8 M undefined130.5 M undefined102.1 M undefined
2005343.4 M undefined92.4 M undefined69 M undefined
2004290 M undefined59.2 M undefined47.5 M undefined

Beijing Tiantan Biological Products Corp stock margins

The Beijing Tiantan Biological Products Corp margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing Tiantan Biological Products Corp. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing Tiantan Biological Products Corp.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Beijing Tiantan Biological Products Corp's sales revenue. A higher gross margin percentage indicates that the Beijing Tiantan Biological Products Corp retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Beijing Tiantan Biological Products Corp's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Beijing Tiantan Biological Products Corp's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Beijing Tiantan Biological Products Corp's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Beijing Tiantan Biological Products Corp. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Beijing Tiantan Biological Products Corp's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Beijing Tiantan Biological Products Corp Margin History

Beijing Tiantan Biological Products Corp Gross marginBeijing Tiantan Biological Products Corp Profit marginBeijing Tiantan Biological Products Corp EBIT marginBeijing Tiantan Biological Products Corp Profit margin
2026e50.72 %31.53 %23.56 %
2025e50.72 %30.36 %23.31 %
2024e50.72 %29.25 %22.87 %
202350.72 %33.13 %21.42 %
202249.02 %31.17 %20.67 %
202147.51 %28.72 %18.48 %
202049.65 %31.05 %18.55 %
201949.83 %31.22 %18.62 %
201847.17 %29.23 %17.38 %
201751.44 %31.27 %47.25 %
201652.09 %20.68 %12.01 %
201543.75 %18.03 %0.62 %
201455.23 %21.72 %7.03 %
201355.9 %30.76 %20.26 %
201258.71 %29.71 %20.29 %
201159.9 %29.09 %16.73 %
201057.23 %22.97 %14.55 %
200962.24 %34.04 %19.24 %
200861.93 %35.24 %19.99 %
200761.72 %36.85 %19.74 %
200655.35 %31.31 %24.5 %
200555.07 %26.91 %20.09 %
200449.59 %20.41 %16.38 %

Beijing Tiantan Biological Products Corp Aktienanalyse

What does Beijing Tiantan Biological Products Corp do?

Beijing Tiantan Biological Products Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Beijing Tiantan Biological Products Corp's Profit Margins

The profit margins of Beijing Tiantan Biological Products Corp represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Beijing Tiantan Biological Products Corp's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Beijing Tiantan Biological Products Corp's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Beijing Tiantan Biological Products Corp's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Beijing Tiantan Biological Products Corp’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Beijing Tiantan Biological Products Corp stock

How much profit has Beijing Tiantan Biological Products Corp made this year?

Beijing Tiantan Biological Products Corp has made 1.37 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by 23.77% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Beijing Tiantan Biological Products Corp publish its earnings?

Beijing Tiantan Biological Products Corp publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Beijing Tiantan Biological Products Corp?

The profits of Beijing Tiantan Biological Products Corp are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Beijing Tiantan Biological Products Corp?

You can learn more about the earnings of Beijing Tiantan Biological Products Corp by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Beijing Tiantan Biological Products Corp pay?

Over the past 12 months, Beijing Tiantan Biological Products Corp paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 0.23 %. For the coming 12 months, Beijing Tiantan Biological Products Corp is expected to pay a dividend of 0.05 CNY.

What is the dividend yield of Beijing Tiantan Biological Products Corp?

The current dividend yield of Beijing Tiantan Biological Products Corp is 0.23 %.

When does Beijing Tiantan Biological Products Corp pay dividends?

Beijing Tiantan Biological Products Corp pays a quarterly dividend. This is distributed in the months of July, August, August, July.

How secure is the dividend of Beijing Tiantan Biological Products Corp?

Beijing Tiantan Biological Products Corp paid dividends every year for the past 10 years.

What is the dividend of Beijing Tiantan Biological Products Corp?

For the upcoming 12 months, dividends amounting to 0.05 CNY are expected. This corresponds to a dividend yield of 0.25 %.

In which sector is Beijing Tiantan Biological Products Corp located?

Beijing Tiantan Biological Products Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Tiantan Biological Products Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Tiantan Biological Products Corp from 6/20/2024 amounting to 0.125 CNY, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.

When did Beijing Tiantan Biological Products Corp pay the last dividend?

The last dividend was paid out on 6/20/2024.

What was the dividend of Beijing Tiantan Biological Products Corp in the year 2023?

In the year 2023, Beijing Tiantan Biological Products Corp distributed 0.083 CNY as dividends.

In which currency does Beijing Tiantan Biological Products Corp pay out the dividend?

The dividends of Beijing Tiantan Biological Products Corp are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beijing Tiantan Biological Products Corp

Our stock analysis for Beijing Tiantan Biological Products Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Tiantan Biological Products Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.